image
Apellis Pharmaceuticals, Inc. APLS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 26.27
-6.38 %
$ 3.27 B
Market Cap
-13.0
P/E
BALANCE SHEET
789 M ASSETS
3.75%
Growth Rates
1Year 3.75%
3Years -6.36%
5Years 31.12%
7Years 61.58%
10Years 65.23%
594 M LIABILITIES
0.65%
Growth Rates
1Year 0.65%
3Years -7.71%
5Years 69.43%
7Years 107.08%
10Years 96.94%
195 M EQUITY
14.51%
Growth Rates
1Year 14.51%
3Years -1.66%
5Years 3.86%
7Years 35.01%
10Years 45.67%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Apellis Pharmaceuticals, Inc.
image
Current Assets 766 M
Cash & Short-Term Investments 352 M
Receivables 206 M
Other Current Assets 208 M
Non-Current Assets 22.4 M
Long-Term Investments 0
PP&E 21.1 M
Other Non-Current Assets 1.31 M
Current Liabilities 248 M
Accounts Payable 37.5 M
Short-Term Debt 6.44 M
Other Current Liabilities 204 M
Non-Current Liabilities 347 M
Long-Term Debt 104 M
Other Non-Current Liabilities 242 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 351.2 551.8 640.2 565.8 352.0 176.3 175.6 24.9 36.0 13.6 4.8
Short Term Investments 4.4 6.5 60.4 311.9 0 0 0 0 0 0 0
Receivables 206.4 7.7 10.1 25.0 0 0 0 0 0 0.5 67.2 K
Inventory 146.4 85.7 16.3 1 0 0 0 0 0 0.1 0.3
Other Current Assets 61.2 73.0 97.1 14.5 21.1 26.2 6.4 2.5 2.0 0.2 0.4
Total Current Assets 766.3 719.5 824.0 917.2 373.1 202.4 182.0 27.4 38.0 14.2 5.2
PP&E 21.1 24.9 26.1 24.5 15.8 1.0 0 0 0 21.7 K 9.13 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 1.3 15.8 31.6 18.9 0.4 0.1 0.1 64.5 K 0.1 37.2 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 788.7 760.2 881.8 960.6 389.2 203.5 182.1 27.4 38.2 14.3 5.2
LIABILITIES
Accounts Payable 37.5 37.3 16.9 8.5 8.4 10.3 3.7 2.5 2.5 0.8 0.4
Short Term Debt 6.4 5.6 4.1 3.7 5.2 1.7 0 0 0 0 0
Other Current Liabilities 203.6 124.6 110.8 116.2 52.2 5.1 2.9 1.1 0.7 0.3 0.3
Total Current Liabilities 247.6 167.6 131.8 128.3 65.8 17.0 6.6 3.6 3.2 1.1 0.7
Long Term Debt 104.5 107.1 206.1 374.0 154.4 25.4 26.4 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 242.1 315.6 345.2 253.6 134.8 0.2 0.2 0 0 0 0
Total Liabilities 594.2 590.3 683.1 756.0 355.0 42.6 33.2 3.6 3.2 1.1 0.7
EQUITY
Common Stock 12 K 11 K 10 K 8 K 6.39 K 5.63 K 5.03 K 843 843 978 978
Retained Earnings (2 837.5) (2 308.9) (1 656.7) (926.3) (581.5) (276.8) (149.3) (98.3) (71.1) (24.6) (13.8)
Other Accumulative Comprehensive Income/Loss (3.5) (0.9) (2.1) (0.1) (0.2) (0.1) 0 0 0 21.5 K 15.6 K
Total Equity 194.5 169.9 198.7 204.6 34.2 161.0 148.9 23.8 35.0 13.2 4.5
Total Liabilities and Equity 788.7 760.2 881.8 960.6 389.2 203.5 182.1 27.4 38.2 14.3 5.2
SHARES OUTSTANDING
Common Shares Outstanding 118.7 106.1 84.4 75.2 62.2 54.4 13.9 18.1 18.1 18.1 18.1